3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
34
Recurrence
4
Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Leukemia, Myeloid, Acute
2
Smoldering Multiple Myeloma
1
Plasmacytoma
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Rituximab
12
acalabrutinib
9
Cyclophosphamide
9
zanubrutinib
7
ibrutinib
7
Magnetic Resonance Spectroscopy
5
venetoclax
4
fludarabine
4
Lenalidomide
4
Cytarabine
4
Cyclosporine
4
CT-P10
4
obinutuzumab
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Vincristine
3
Specimen Handling
3
Mycophenolic Acid
3
Methotrexate
3
Doxorubicin
3
Bendamustine Hydrochloride
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Immunotherapy, Adoptive
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
daratumumab
×
30 days
×
Clear all
No trials found.